Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Patrick Johnston

Concepts (729)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
59
2026
192
11.540
Why?
Lymphoma, Non-Hodgkin
38
2026
124
6.970
Why?
Hematopoietic Stem Cell Transplantation
35
2026
675
5.040
Why?
Visual Perception
7
2025
183
3.170
Why?
Antineoplastic Combined Chemotherapy Protocols
47
2026
1953
3.140
Why?
Transplantation, Autologous
34
2026
290
3.080
Why?
Lymphoma
18
2024
232
2.670
Why?
Immunotherapy, Adoptive
23
2026
337
2.480
Why?
Hodgkin Disease
18
2026
171
2.370
Why?
Salvage Therapy
13
2024
162
2.320
Why?
Lymphoma, B-Cell
16
2026
132
2.270
Why?
Neoplasm Recurrence, Local
25
2026
1137
2.160
Why?
Antigens, CD19
12
2024
129
2.140
Why?
Central Nervous System Neoplasms
11
2026
173
2.140
Why?
Reaction Time
6
2025
438
1.840
Why?
Visual Cortex
2
2025
84
1.620
Why?
Rituximab
28
2025
209
1.430
Why?
Lymphoma, Follicular
13
2025
56
1.410
Why?
Biological Products
9
2023
252
1.170
Why?
Aged
122
2026
25913
1.150
Why?
Everolimus
11
2018
111
1.050
Why?
Adult
128
2026
40449
1.040
Why?
Middle Aged
132
2026
35875
1.040
Why?
Humans
235
2026
144759
1.000
Why?
Retrospective Studies
63
2026
17066
0.940
Why?
Male
152
2026
72315
0.940
Why?
Granulocyte Colony-Stimulating Factor
5
2021
89
0.920
Why?
Aged, 80 and over
61
2026
8265
0.920
Why?
Young Adult
55
2026
14105
0.900
Why?
Lymphocytes
9
2026
382
0.890
Why?
Evoked Potentials
4
2025
128
0.880
Why?
Female
145
2026
78271
0.870
Why?
Prognosis
45
2026
4282
0.800
Why?
Disease-Free Survival
29
2023
769
0.800
Why?
Monocytes
9
2019
538
0.740
Why?
Antineoplastic Agents
18
2021
2194
0.720
Why?
Photic Stimulation
5
2025
264
0.710
Why?
Attention
2
2025
457
0.710
Why?
Waldenstrom Macroglobulinemia
5
2023
19
0.700
Why?
Fluorodeoxyglucose F18
8
2024
156
0.700
Why?
Peripheral Blood Stem Cell Transplantation
10
2015
35
0.700
Why?
Lymphocyte Count
17
2022
164
0.690
Why?
Sirolimus
6
2015
281
0.680
Why?
Recurrence
17
2024
1135
0.670
Why?
Lymphoma, Mantle-Cell
6
2022
32
0.670
Why?
Electroencephalography
6
2025
532
0.660
Why?
Brain Mapping
6
2022
536
0.660
Why?
Cyclophosphamide
15
2025
266
0.660
Why?
Radiopharmaceuticals
6
2021
194
0.630
Why?
Multiple Myeloma
7
2023
291
0.600
Why?
Neurotoxicity Syndromes
4
2023
38
0.590
Why?
Treatment Outcome
41
2026
11679
0.590
Why?
Doxorubicin
13
2025
397
0.570
Why?
Retinal Neoplasms
5
2018
37
0.560
Why?
Retinal Detachment
6
2009
72
0.560
Why?
Vincristine
11
2025
140
0.560
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
5
2021
76
0.550
Why?
Survival Rate
21
2021
2089
0.530
Why?
Spatial Processing
1
2017
1
0.520
Why?
Neoplasms, Second Primary
2
2017
100
0.500
Why?
Positron-Emission Tomography
7
2024
323
0.500
Why?
Prednisone
10
2025
221
0.490
Why?
Time Perception
1
2017
33
0.490
Why?
Antibodies, Monoclonal, Murine-Derived
11
2017
97
0.480
Why?
Combined Modality Therapy
9
2024
1266
0.470
Why?
Brain
7
2021
2933
0.470
Why?
Methotrexate
4
2025
240
0.460
Why?
Transplantation Conditioning
10
2015
186
0.450
Why?
Cell Transformation, Neoplastic
5
2019
339
0.450
Why?
Drug Resistance, Neoplasm
8
2025
881
0.440
Why?
Face
1
2016
173
0.440
Why?
Stem Cell Transplantation
7
2021
191
0.440
Why?
Antibodies, Monoclonal
9
2017
1519
0.440
Why?
Vitreous Body
7
2018
117
0.430
Why?
Piperidines
5
2022
217
0.430
Why?
Survival Analysis
19
2021
1382
0.420
Why?
Autografts
6
2022
55
0.410
Why?
Antineoplastic Agents, Immunological
3
2021
199
0.410
Why?
Follow-Up Studies
24
2025
5408
0.400
Why?
Synovial Cyst
1
2013
4
0.390
Why?
Positron Emission Tomography Computed Tomography
4
2023
117
0.380
Why?
Amyloidosis
4
2018
44
0.370
Why?
Pyrimidines
6
2025
532
0.370
Why?
Antigens, CD20
5
2017
35
0.360
Why?
Wrist
1
2013
60
0.360
Why?
Pyrazoles
5
2022
509
0.360
Why?
Lymphoma, B-Cell, Marginal Zone
3
2022
19
0.360
Why?
Fingers
1
2013
107
0.360
Why?
Radioimmunotherapy
4
2017
22
0.350
Why?
Lymphoma, T-Cell
3
2015
29
0.330
Why?
Eye Neoplasms
5
2014
30
0.320
Why?
Protein-Tyrosine Kinases
3
2009
433
0.310
Why?
Adolescent
34
2026
22428
0.310
Why?
Orthopedic Procedures
1
2013
243
0.310
Why?
Lasers, Solid-State
1
2009
22
0.290
Why?
Neoplasm Proteins
4
2019
442
0.290
Why?
Burkitt Lymphoma
3
2022
62
0.290
Why?
Neoplasm Staging
12
2020
1462
0.280
Why?
Cataract Extraction
2
2009
119
0.280
Why?
Molecular Targeted Therapy
2
2010
432
0.280
Why?
Magnetic Resonance Imaging
10
2026
3863
0.280
Why?
Kaplan-Meier Estimate
12
2018
965
0.270
Why?
Risk Factors
23
2022
10779
0.270
Why?
Thalidomide
3
2018
43
0.270
Why?
Killer Cells, Natural
4
2023
467
0.260
Why?
Mechanistic Target of Rapamycin Complex 1
4
2018
139
0.260
Why?
Dexamethasone
6
2022
372
0.260
Why?
Hematopoietic Stem Cell Mobilization
3
2012
27
0.250
Why?
Pattern Recognition, Visual
2
2025
105
0.250
Why?
Lymphoma, T-Cell, Peripheral
2
2024
20
0.240
Why?
Transfusion Reaction
1
2006
63
0.240
Why?
Castleman Disease
1
2026
16
0.240
Why?
TOR Serine-Threonine Kinases
4
2017
449
0.240
Why?
Chemoradiotherapy
2
2021
237
0.230
Why?
Fracture Fixation
1
2006
79
0.230
Why?
Circulating Tumor DNA
1
2026
43
0.230
Why?
Hip Fractures
1
2006
84
0.230
Why?
RNA, Small Interfering
2
2007
635
0.230
Why?
Peripheral Nervous System Neoplasms
1
2025
19
0.230
Why?
Event-Related Potentials, P300
1
2025
15
0.220
Why?
Adaptation, Physiological
2
2022
570
0.220
Why?
Eye Injuries
3
1991
53
0.220
Why?
Central Nervous System
3
2023
281
0.220
Why?
Thrombocytopenia
3
2022
205
0.220
Why?
B-Lymphocytes
6
2023
876
0.220
Why?
Medical Oncology
2
2026
332
0.210
Why?
Skin Neoplasms
2
2022
847
0.210
Why?
Lymphohistiocytosis, Hemophagocytic
1
2024
29
0.210
Why?
Acute Kidney Injury
2
2022
865
0.210
Why?
Perioperative Care
1
2006
231
0.210
Why?
Appendicitis
1
2026
148
0.210
Why?
Mediastinal Neoplasms
1
2024
51
0.210
Why?
Conditioning, Classical
2
2022
120
0.210
Why?
Cancer Vaccines
1
2025
160
0.200
Why?
Hepatitis A
1
2024
25
0.200
Why?
Multiprotein Complexes
3
2017
172
0.200
Why?
Aqueous Humor
2
2014
38
0.200
Why?
Incidence
9
2024
2879
0.200
Why?
Fear
2
2022
366
0.200
Why?
Orientation
1
2023
50
0.190
Why?
Immunoglobulin kappa-Chains
2
2014
23
0.190
Why?
Hydroxamic Acids
2
2014
94
0.190
Why?
Standard of Care
4
2025
80
0.190
Why?
Predictive Value of Tests
11
2018
2115
0.190
Why?
Immunologic Factors
3
2014
255
0.190
Why?
Prospective Studies
15
2025
7990
0.190
Why?
Extinction, Psychological
2
2022
92
0.190
Why?
Venous Thromboembolism
2
2022
324
0.190
Why?
Cell- and Tissue-Based Therapy
4
2024
80
0.190
Why?
Cerebellum
2
2017
223
0.190
Why?
Facial Expression
1
2023
74
0.180
Why?
Vitamin D Deficiency
2
2017
186
0.180
Why?
Tomography, X-Ray Computed
4
2016
2730
0.180
Why?
Yttrium Radioisotopes
4
2017
64
0.180
Why?
Electromyography
1
2024
415
0.180
Why?
Carmustine
2
2020
52
0.180
Why?
Brain Diseases
1
2023
152
0.180
Why?
Transcription Factors
1
2010
1741
0.180
Why?
Myeloid Differentiation Factor 88
2
2019
114
0.180
Why?
Bortezomib
4
2018
55
0.170
Why?
Immunoglobulin Light Chains
3
2013
51
0.170
Why?
Status Epilepticus
1
2022
56
0.170
Why?
Facial Recognition
1
2022
35
0.170
Why?
Cohort Studies
13
2026
5960
0.170
Why?
Magnesium Deficiency
1
2021
2
0.170
Why?
Central Nervous System Diseases
1
2022
74
0.170
Why?
Hypoalbuminemia
1
2021
28
0.170
Why?
Measles virus
3
2010
21
0.170
Why?
Fluorine Radioisotopes
1
2021
13
0.170
Why?
Immunoconjugates
1
2022
132
0.170
Why?
Space Perception
1
2021
83
0.170
Why?
Bacterial Infections
1
2023
246
0.160
Why?
Magnesium
1
2021
155
0.160
Why?
Autism Spectrum Disorder
2
2017
412
0.160
Why?
Vision, Ocular
1
2020
47
0.160
Why?
Cytokines
4
2021
2061
0.160
Why?
Antigens, CD34
2
2010
88
0.160
Why?
Schizophrenia
2
2017
446
0.160
Why?
Medication Systems
1
2000
3
0.160
Why?
Testis
1
2021
163
0.160
Why?
Autoimmunity
2
2018
926
0.160
Why?
Molecular Epidemiology
2
2017
73
0.160
Why?
Filgrastim
2
2017
13
0.160
Why?
Heterocyclic Compounds
2
2012
23
0.160
Why?
Retinal Perforations
3
1996
18
0.160
Why?
Lymphopenia
2
2010
65
0.150
Why?
Automation
1
2000
102
0.150
Why?
Leukemia, B-Cell
1
2019
12
0.150
Why?
Melphalan
4
2017
42
0.150
Why?
Nursing Staff
1
2000
41
0.150
Why?
Leg
1
2021
239
0.150
Why?
Drug Administration Schedule
8
2017
779
0.150
Why?
Cost-Benefit Analysis
1
2022
634
0.150
Why?
Proportional Hazards Models
7
2023
1325
0.150
Why?
Protein Kinase Inhibitors
4
2019
969
0.150
Why?
Recombinant Proteins
3
2017
1370
0.150
Why?
Enterocolitis, Necrotizing
2
2010
41
0.150
Why?
Cues
1
2021
326
0.150
Why?
Infusions, Parenteral
1
2018
41
0.140
Why?
Time Factors
12
2019
7173
0.140
Why?
Leukocyte Count
3
2014
316
0.140
Why?
Vidarabine
4
2017
32
0.140
Why?
Mental Recall
1
2020
222
0.140
Why?
Janus Kinase 1
1
2018
26
0.140
Why?
Child
16
2026
22633
0.140
Why?
Myeloid-Derived Suppressor Cells
1
2019
72
0.140
Why?
Autistic Disorder
2
2011
211
0.140
Why?
Drug Approval
2
2010
89
0.130
Why?
Thrombosis
1
2022
393
0.130
Why?
Mutation, Missense
1
2019
340
0.130
Why?
Leukapheresis
2
2016
27
0.130
Why?
Northern Ireland
5
2009
12
0.130
Why?
Class I Phosphatidylinositol 3-Kinases
1
2018
108
0.130
Why?
Contingent Negative Variation
1
2017
9
0.130
Why?
Immunoglobulin lambda-Chains
2
2014
9
0.130
Why?
Postoperative Complications
2
2006
2919
0.130
Why?
Immunotherapy
2
2019
653
0.130
Why?
Waste Disposal, Fluid
1
2017
53
0.130
Why?
Delay Discounting
1
2017
29
0.130
Why?
Lipopolysaccharide Receptors
1
2017
87
0.130
Why?
Visual Fields
2
2017
115
0.130
Why?
Evoked Potentials, Visual
1
2017
42
0.130
Why?
Immunophenotyping
2
2015
322
0.120
Why?
Fluorouracil
2
2016
235
0.120
Why?
Maximum Tolerated Dose
4
2019
212
0.120
Why?
Tarsal Coalition
1
2016
1
0.120
Why?
Subtalar Joint
1
2016
5
0.120
Why?
Evoked Potentials, Auditory
1
2017
180
0.120
Why?
Magnetoencephalography
1
2017
160
0.120
Why?
Visual Acuity
4
1996
489
0.120
Why?
Glycine
1
2017
187
0.120
Why?
Case-Control Studies
6
2021
3604
0.120
Why?
Time-to-Treatment
1
2018
243
0.120
Why?
Body Fluids
1
1996
70
0.110
Why?
Uveitis
2
2014
148
0.110
Why?
Mental Processes
1
2015
38
0.110
Why?
Biomarkers
6
2023
4271
0.110
Why?
Odds Ratio
4
2018
1075
0.110
Why?
Dendritic Cells
1
2019
499
0.110
Why?
Myelodysplastic Syndromes
1
2017
147
0.110
Why?
Antipsychotic Agents
1
2017
213
0.110
Why?
Hemangioma, Capillary
1
1995
14
0.110
Why?
Outpatients
1
2018
442
0.110
Why?
Lymphoma, Large-Cell, Immunoblastic
1
2014
1
0.110
Why?
Comprehension
1
2017
180
0.110
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
257
0.110
Why?
Folic Acid
1
2016
199
0.110
Why?
United States
6
2025
15966
0.110
Why?
Psychotic Disorders
1
2017
186
0.110
Why?
Environmental Monitoring
1
2017
377
0.110
Why?
Boronic Acids
2
2014
37
0.110
Why?
Polyethylene Glycols
2
2017
654
0.110
Why?
Interleukin-10
2
2013
309
0.110
Why?
Translocation, Genetic
2
2022
115
0.110
Why?
Obsessive-Compulsive Disorder
1
2015
58
0.100
Why?
Optic Disk
1
1995
53
0.100
Why?
Task Performance and Analysis
1
2015
198
0.100
Why?
Water Pollutants, Chemical
1
2017
234
0.100
Why?
Prefrontal Cortex
1
2017
328
0.100
Why?
Biomarkers, Tumor
4
2013
1313
0.100
Why?
Neoplasms
2
2022
2875
0.100
Why?
Myeloid Cells
1
2015
148
0.100
Why?
Pyrazines
2
2014
92
0.100
Why?
Autoimmune Diseases
2
2018
463
0.100
Why?
Feasibility Studies
2
2016
1095
0.100
Why?
Heart Atria
1
2014
144
0.100
Why?
Polyneuropathies
1
2013
57
0.100
Why?
Intestinal Neoplasms
1
2013
30
0.100
Why?
Indoles
2
2014
501
0.100
Why?
Intestinal Perforation
1
2013
44
0.100
Why?
Tachycardia, Supraventricular
1
2013
45
0.100
Why?
Oligodeoxyribonucleotides
1
2013
141
0.100
Why?
Retinal Neovascularization
1
1993
29
0.090
Why?
Quality Assurance, Health Care
2
2008
340
0.090
Why?
Remission Induction
4
2017
307
0.090
Why?
T-Lymphocytes
3
2018
1982
0.090
Why?
POEMS Syndrome
1
2012
3
0.090
Why?
Peripheral Nerves
1
2013
72
0.090
Why?
Programmed Cell Death 1 Receptor
1
2014
264
0.090
Why?
Scleral Diseases
1
1992
2
0.090
Why?
Anti-Bacterial Agents
2
2023
1907
0.090
Why?
Hematologic Neoplasms
2
2013
161
0.090
Why?
Disease Progression
6
2021
2847
0.090
Why?
Cell Proliferation
3
2015
2496
0.090
Why?
Carbonated Beverages
1
1991
16
0.090
Why?
Corneal Diseases
1
1992
46
0.090
Why?
Attitude of Health Personnel
1
2000
1185
0.090
Why?
Epidermolysis Bullosa Dystrophica
1
1992
42
0.090
Why?
Child, Preschool
6
2026
11787
0.090
Why?
Soft Tissue Neoplasms
1
2013
127
0.090
Why?
Gene Expression Profiling
2
2011
1782
0.080
Why?
Sensitivity and Specificity
4
2026
1985
0.080
Why?
Stomach Neoplasms
1
2013
126
0.080
Why?
Contrast Media
2
2026
488
0.080
Why?
Disease Management
2
2026
645
0.080
Why?
Oncolytic Virotherapy
1
2010
13
0.080
Why?
Blast Injuries
1
1991
63
0.080
Why?
Proto-Oncogene Proteins c-bcl-2
2
2022
240
0.080
Why?
Oncolytic Viruses
1
2010
8
0.080
Why?
Gene Targeting
1
2010
82
0.080
Why?
Samarium
1
2010
1
0.080
Why?
Myeloablative Agonists
1
2010
23
0.080
Why?
Radioisotopes
1
2010
33
0.080
Why?
Cornea
1
1992
155
0.080
Why?
X-Ray Intensifying Screens
1
2010
3
0.080
Why?
Miosis
1
1990
4
0.080
Why?
Arrhythmias, Cardiac
1
2013
361
0.080
Why?
Gray Matter
1
2011
91
0.080
Why?
Self Report
1
2015
872
0.080
Why?
Short Bowel Syndrome
1
2010
27
0.080
Why?
Immunosuppressive Agents
1
2015
846
0.080
Why?
Leukemia, Myeloid, Acute
1
2017
682
0.080
Why?
Surveys and Questionnaires
3
2022
6048
0.080
Why?
Gene Expression Regulation, Neoplastic
2
2014
1455
0.080
Why?
Holidays
1
2009
8
0.080
Why?
Child Development Disorders, Pervasive
1
2010
62
0.080
Why?
Indomethacin
1
1990
76
0.080
Why?
Radiometry
1
2010
56
0.080
Why?
Minnesota
4
2013
169
0.080
Why?
Oxazines
1
2009
37
0.080
Why?
Iris Diseases
1
1989
7
0.080
Why?
Electronics
1
2010
71
0.080
Why?
Interleukin-15
1
2010
97
0.080
Why?
Subtraction Technique
1
2009
26
0.080
Why?
Uveal Neoplasms
1
1989
16
0.080
Why?
Pain Threshold
1
2009
73
0.080
Why?
Severity of Illness Index
4
2015
2925
0.070
Why?
Organophosphorus Compounds
1
2010
85
0.070
Why?
Organometallic Compounds
1
2010
112
0.070
Why?
Lenses, Intraocular
1
1989
49
0.070
Why?
Quinolones
1
2011
201
0.070
Why?
Fatigue
2
2024
366
0.070
Why?
Radiation Dosage
1
2010
192
0.070
Why?
Chromosomes, Human, Pair 6
1
2008
46
0.070
Why?
Multivariate Analysis
5
2012
1539
0.070
Why?
Marijuana Abuse
1
2011
211
0.070
Why?
Double-Blind Method
3
2019
2029
0.070
Why?
Neurons
2
2009
1640
0.070
Why?
Treatment Failure
2
2024
365
0.070
Why?
Hospitalization
1
2018
2433
0.070
Why?
Amygdala
1
2009
198
0.070
Why?
Vancomycin Resistance
1
2007
16
0.070
Why?
Gases
1
1988
53
0.070
Why?
Fluorescein Angiography
3
1996
189
0.070
Why?
Ambulatory Surgical Procedures
1
2008
80
0.070
Why?
Down-Regulation
2
2007
627
0.070
Why?
Ophthalmoplegia
1
1987
13
0.070
Why?
Enterococcus
1
2007
22
0.070
Why?
Germinal Center
1
2008
67
0.070
Why?
Torticollis
1
1987
17
0.070
Why?
Obesity
1
2021
3077
0.070
Why?
Cytarabine
3
2017
66
0.070
Why?
Chromosomes, Human, Pair 2
1
2007
28
0.070
Why?
Chromosomes, Human, Pair 5
1
2007
28
0.070
Why?
Rhinoplasty
1
2008
37
0.060
Why?
Models, Neurological
1
2009
254
0.060
Why?
Logistic Models
4
2018
2117
0.060
Why?
Infant, Premature, Diseases
1
2008
111
0.060
Why?
Proto-Oncogene Proteins c-bcl-6
2
2022
11
0.060
Why?
Carrier State
1
2007
79
0.060
Why?
Temporal Lobe
2
2022
104
0.060
Why?
Emotions
2
2023
578
0.060
Why?
Atrial Fibrillation
1
2013
550
0.060
Why?
Immunohistochemistry
5
2012
1716
0.060
Why?
Vitamin D
1
2010
400
0.060
Why?
Ki-1 Antigen
1
2006
7
0.060
Why?
Flow Cytometry
4
2015
1173
0.060
Why?
Prosthesis Implantation
1
2008
153
0.060
Why?
Diagnosis, Differential
2
2026
1489
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2009
459
0.060
Why?
Radiotherapy Dosage
2
2021
289
0.060
Why?
Proto-Oncogene Proteins c-jun
1
2006
55
0.060
Why?
Seat Belts
1
1986
23
0.060
Why?
Eye
1
2007
109
0.060
Why?
Quality of Life
3
2023
3185
0.060
Why?
Behavior, Animal
1
2009
519
0.060
Why?
Reproducibility of Results
4
2015
3409
0.060
Why?
Cerebral Cortex
1
2009
464
0.060
Why?
ROC Curve
2
2023
614
0.060
Why?
Lymphocyte Depletion
1
2006
132
0.060
Why?
Lens, Crystalline
1
1987
136
0.060
Why?
Hematopoietic Stem Cells
2
2010
420
0.060
Why?
Anemia
2
2018
188
0.060
Why?
Neoplasm, Residual
1
2026
139
0.060
Why?
Signal Transduction
2
2010
5226
0.060
Why?
Pyridines
1
2009
605
0.060
Why?
Isoquinolines
1
2025
44
0.060
Why?
Retreatment
2
2017
77
0.060
Why?
Melanoma
2
1989
761
0.060
Why?
Risk Assessment
4
2018
3671
0.060
Why?
Amyloid
1
2006
92
0.060
Why?
Cross Infection
1
2007
262
0.050
Why?
Pregnanolone
1
2005
35
0.050
Why?
Neoplasm Grading
2
2018
307
0.050
Why?
Induction Chemotherapy
1
2025
87
0.050
Why?
Cisplatin
2
2022
334
0.050
Why?
Cognition
2
2024
1266
0.050
Why?
Thiophenes
1
2025
128
0.050
Why?
Algorithms
1
2012
1837
0.050
Why?
Vitrectomy
2
2013
73
0.050
Why?
Aminopterin
1
2024
3
0.050
Why?
Glaucoma
1
1987
250
0.050
Why?
Regression Analysis
1
2006
1003
0.050
Why?
Proteins
1
2010
1021
0.050
Why?
Psychiatric Status Rating Scales
2
2017
541
0.050
Why?
Apoptosis
2
2015
2430
0.050
Why?
Biopsy
2
2019
1075
0.050
Why?
Area Under Curve
2
2017
330
0.050
Why?
Immunoglobulins, Intravenous
1
2024
126
0.050
Why?
Acute Disease
1
2026
1030
0.050
Why?
Anger
1
2023
60
0.050
Why?
HLA-DR Antigens
1
2023
220
0.050
Why?
Lactate Dehydrogenases
1
2022
6
0.050
Why?
Risk
3
2010
911
0.050
Why?
Statistics, Nonparametric
2
2017
427
0.050
Why?
Thymidylate Synthase
1
2002
13
0.050
Why?
Syndrome
1
2023
380
0.050
Why?
Creatine Kinase
1
2022
72
0.050
Why?
Cell Line, Tumor
2
2007
3540
0.050
Why?
Patient Selection
1
2006
719
0.040
Why?
Agraphia
1
2021
1
0.040
Why?
Body Weight
2
2021
976
0.040
Why?
Organ Size
2
2014
463
0.040
Why?
Gene Expression Regulation
1
2011
2608
0.040
Why?
Ki-67 Antigen
1
2002
117
0.040
Why?
Hematologic Diseases
2
2014
66
0.040
Why?
Pain
3
2014
779
0.040
Why?
L-Lactate Dehydrogenase
2
2013
115
0.040
Why?
Confusion
1
2021
30
0.040
Why?
Aphasia
1
2021
24
0.040
Why?
Wounds and Injuries
1
2009
956
0.040
Why?
Uric Acid
1
2022
166
0.040
Why?
Clinical Trials as Topic
1
2006
1053
0.040
Why?
Cell Cycle Proteins
1
2005
628
0.040
Why?
DNA-Binding Proteins
1
2008
1499
0.040
Why?
Proto-Oncogene Proteins c-myc
1
2022
167
0.040
Why?
Glass
2
2009
46
0.040
Why?
Stem Cells
1
2005
626
0.040
Why?
Galvanic Skin Response
1
2020
26
0.040
Why?
Radiotherapy
1
2021
206
0.040
Why?
In Situ Hybridization, Fluorescence
1
2021
322
0.040
Why?
Serum Albumin
1
2021
147
0.040
Why?
Electroshock
1
2020
145
0.040
Why?
Creatinine
1
2022
506
0.040
Why?
Disease Susceptibility
1
2022
348
0.040
Why?
Manitoba
1
2000
4
0.040
Why?
Benzylamines
2
2012
43
0.040
Why?
Receptors, Antigen, T-Cell
1
2023
668
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2026
985
0.040
Why?
Transplantation, Homologous
2
2013
415
0.040
Why?
Colonic Neoplasms
1
2002
259
0.040
Why?
Age Factors
2
2021
3333
0.040
Why?
Vinblastine
1
2019
75
0.040
Why?
Dacarbazine
1
2019
100
0.040
Why?
Vero Cells
2
2010
84
0.040
Why?
Medication Errors
1
2000
83
0.040
Why?
Neoplasm Invasiveness
1
2021
508
0.040
Why?
Amino Acid Substitution
1
2019
304
0.040
Why?
Administration, Oral
2
2012
847
0.040
Why?
Antibodies, Viral
1
2023
672
0.040
Why?
Gamma Rays
1
2018
56
0.040
Why?
Cluster Analysis
2
2014
521
0.040
Why?
Intravitreal Injections
1
2018
71
0.040
Why?
Immunoglobulin G
1
2023
893
0.040
Why?
Injections, Intravenous
1
2018
200
0.040
Why?
Aging
1
2009
1966
0.030
Why?
Blotting, Western
2
2015
1187
0.030
Why?
Hospitals, Teaching
1
2018
119
0.030
Why?
Chi-Square Distribution
2
2010
529
0.030
Why?
Anthracyclines
1
2018
47
0.030
Why?
Seizures
1
2022
460
0.030
Why?
Brain Neoplasms
1
2007
1318
0.030
Why?
Tumor Suppressor Protein p53
1
2002
529
0.030
Why?
Bleomycin
1
2019
253
0.030
Why?
Nursing Homes
1
2000
172
0.030
Why?
Water Movements
1
2017
29
0.030
Why?
Bendamustine Hydrochloride
1
2017
17
0.030
Why?
Plasma Exchange
1
2017
18
0.030
Why?
United Kingdom
1
2018
338
0.030
Why?
Organoplatinum Compounds
1
2017
66
0.030
Why?
Etoposide
2
2008
166
0.030
Why?
Infant
3
2024
10034
0.030
Why?
Immunoglobulin M
1
2018
284
0.030
Why?
Rain
1
2017
49
0.030
Why?
Cell Count
2
2009
320
0.030
Why?
Dose-Response Relationship, Drug
2
2011
2027
0.030
Why?
Cell Separation
2
2010
307
0.030
Why?
Animals
8
2015
38058
0.030
Why?
Green Fluorescent Proteins
2
2010
405
0.030
Why?
Neoplasms, Radiation-Induced
1
2017
99
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
161
0.030
Why?
Oligonucleotide Array Sequence Analysis
2
2011
758
0.030
Why?
Intensive Care Units
1
2022
916
0.030
Why?
Image Processing, Computer-Assisted
2
2011
780
0.030
Why?
Neutropenia
1
2017
155
0.030
Why?
Blood-Retinal Barrier
1
1996
12
0.030
Why?
von Hippel-Lindau Disease
1
1996
12
0.030
Why?
Particle Size
1
2017
411
0.030
Why?
Retina
1
2018
324
0.030
Why?
Fundus Oculi
1
1996
89
0.030
Why?
Acoustic Stimulation
1
2017
333
0.030
Why?
Chemotherapy, Adjuvant
1
2017
421
0.030
Why?
Registries
2
2017
2385
0.030
Why?
Functional Neuroimaging
1
2015
60
0.030
Why?
Extracellular Space
1
1996
120
0.030
Why?
Models, Theoretical
1
2018
582
0.030
Why?
Mechanistic Target of Rapamycin Complex 2
1
2015
63
0.030
Why?
Foot
1
2016
100
0.030
Why?
Cross-Sectional Studies
2
2017
5868
0.030
Why?
Adenine
1
2017
339
0.030
Why?
France
1
2014
40
0.030
Why?
Ankle Joint
1
2016
122
0.030
Why?
Analysis of Variance
2
2009
1306
0.030
Why?
Anxiety
1
2022
1109
0.030
Why?
Clone Cells
1
2014
266
0.030
Why?
Polyradiculoneuropathy
1
2013
4
0.030
Why?
Paraneoplastic Syndromes, Nervous System
1
2013
14
0.030
Why?
Mitral Valve Insufficiency
1
2014
72
0.030
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
20
0.030
Why?
Ambulatory Care
1
2018
600
0.030
Why?
Guillain-Barre Syndrome
1
2013
22
0.030
Why?
Transfection
2
2006
940
0.020
Why?
Sciatic Nerve
1
2013
59
0.020
Why?
Immunoassay
1
2014
109
0.020
Why?
Survival
1
2013
38
0.020
Why?
In Vitro Techniques
1
2015
1047
0.020
Why?
Tumor Cells, Cultured
1
2015
919
0.020
Why?
Lymphatic Metastasis
1
2014
333
0.020
Why?
Patient Reported Outcome Measures
1
2017
488
0.020
Why?
Immunoenzyme Techniques
1
2013
200
0.020
Why?
Device Removal
1
2014
143
0.020
Why?
In Situ Hybridization
1
2013
319
0.020
Why?
Medical Records
1
2013
187
0.020
Why?
Vision, Binocular
1
1993
47
0.020
Why?
Heart Valve Prosthesis
1
2014
134
0.020
Why?
Psychomotor Performance
1
2015
328
0.020
Why?
Plasmacytoma
1
2012
19
0.020
Why?
Brachytherapy
1
2013
134
0.020
Why?
Transcription, Genetic
2
2011
1496
0.020
Why?
Neuropsychological Tests
1
2017
1134
0.020
Why?
Horner Syndrome
1
1992
7
0.020
Why?
Heart Valve Prosthesis Implantation
1
2014
197
0.020
Why?
False Positive Reactions
1
2012
121
0.020
Why?
Gastrointestinal Diseases
1
2014
216
0.020
Why?
Research Design
1
2018
1135
0.020
Why?
Explosions
1
1991
15
0.020
Why?
Costs and Cost Analysis
1
2012
219
0.020
Why?
Hippocampus
2
2009
965
0.020
Why?
Farnesyltranstransferase
1
2011
21
0.020
Why?
Diagnostic Imaging
1
2014
338
0.020
Why?
Food Labeling
1
1991
13
0.020
Why?
Diagnostic Techniques, Ophthalmological
1
2011
53
0.020
Why?
Immunologic Techniques
1
2011
38
0.020
Why?
Tomography, Optical Coherence
1
2013
271
0.020
Why?
Interleukin-1beta
1
2013
395
0.020
Why?
Databases, Factual
1
2017
1486
0.020
Why?
RNA Splicing Factors
1
2011
64
0.020
Why?
Blood Viscosity
1
2010
18
0.020
Why?
Iowa
1
2010
32
0.020
Why?
Psychometrics
1
2015
734
0.020
Why?
Plasmapheresis
1
2010
22
0.020
Why?
Phosphorylation
1
2015
1732
0.020
Why?
Secondary Prevention
1
2012
254
0.020
Why?
Intelligence Tests
1
2010
56
0.020
Why?
Gastrointestinal Tract
1
2013
208
0.020
Why?
Prostaglandin Antagonists
1
1990
3
0.020
Why?
Cells, Cultured
2
2010
4154
0.020
Why?
Drug Therapy, Combination
2
2010
1047
0.020
Why?
Silicon
1
2010
22
0.020
Why?
Early Medical Intervention
1
2010
61
0.020
Why?
Transplantation Chimera
1
2010
56
0.020
Why?
Frontal Lobe
1
2011
160
0.020
Why?
Syk Kinase
1
2009
22
0.020
Why?
Exons
1
2011
358
0.020
Why?
Cannabinoid Receptor Antagonists
1
2009
1
0.020
Why?
Receptors, Cannabinoid
1
2009
14
0.020
Why?
Accidents, Home
1
2009
33
0.020
Why?
Administration, Topical
1
1990
150
0.020
Why?
Poisson Distribution
1
2009
78
0.020
Why?
Boston
1
2009
92
0.020
Why?
Equipment Failure Analysis
1
2010
128
0.020
Why?
Tissue Distribution
1
2010
327
0.020
Why?
Ophthalmic Solutions
1
1990
79
0.020
Why?
Medulla Oblongata
1
2009
37
0.020
Why?
Mice, SCID
1
2010
369
0.020
Why?
Statistics as Topic
1
2010
284
0.020
Why?
Inflammation
1
2021
2878
0.020
Why?
Periaqueductal Gray
1
2009
37
0.020
Why?
Lacerations
1
2009
40
0.020
Why?
Formaldehyde
1
2009
66
0.020
Why?
Endophthalmitis
1
1989
45
0.020
Why?
Random Allocation
1
1990
363
0.020
Why?
Tumor Burden
1
2010
319
0.020
Why?
White Matter
1
2011
153
0.020
Why?
Morpholines
1
2009
128
0.020
Why?
Macular Edema
1
1989
49
0.020
Why?
Catheters, Indwelling
1
2009
96
0.020
Why?
Vision Disorders
1
1991
178
0.020
Why?
Aminopyridines
1
2009
127
0.020
Why?
Cataract
1
1992
238
0.020
Why?
Atrophy
1
2009
201
0.020
Why?
Alternative Splicing
1
2011
247
0.020
Why?
Proto-Oncogene Proteins c-fos
1
2009
196
0.020
Why?
Prevalence
1
2016
2834
0.020
Why?
Rats
2
2009
5597
0.020
Why?
Intraoperative Complications
1
1990
155
0.020
Why?
Bone Marrow
1
2010
304
0.020
Why?
Diarrhea
1
2009
192
0.020
Why?
Sulfur Hexafluoride
1
1988
2
0.020
Why?
Factor Analysis, Statistical
1
2009
293
0.020
Why?
Prednisolone
1
1988
66
0.020
Why?
Foreign Bodies
1
2009
107
0.020
Why?
Mucositis
1
2008
20
0.020
Why?
Methods
1
1988
69
0.020
Why?
Chromatography, Liquid
1
2010
454
0.020
Why?
Hot Temperature
1
1991
407
0.020
Why?
Orbital Diseases
1
1988
35
0.020
Why?
Tumor Necrosis Factor-alpha
1
2013
1217
0.020
Why?
Blindness
1
1988
52
0.020
Why?
Air
1
1988
45
0.020
Why?
Lymphocyte Subsets
1
2008
83
0.020
Why?
Silicones
1
2008
29
0.020
Why?
Polyethylenes
1
2008
11
0.020
Why?
Equipment Design
1
2010
530
0.020
Why?
Vasculitis
1
1988
69
0.020
Why?
Polytetrafluoroethylene
1
2008
25
0.020
Why?
Purine-Nucleoside Phosphorylase
1
2007
6
0.020
Why?
Membrane Cofactor Protein
1
2007
14
0.020
Why?
Pneumonia
1
2014
631
0.020
Why?
Sequence Deletion
1
2008
193
0.020
Why?
Up-Regulation
1
2011
851
0.020
Why?
Vitreous Hemorrhage
1
1987
10
0.020
Why?
Leukocytes, Mononuclear
1
2010
573
0.020
Why?
Timolol
1
1987
14
0.020
Why?
Enzyme Inhibitors
1
2011
824
0.020
Why?
Pilocarpine
1
1987
16
0.020
Why?
Ifosfamide
1
2007
38
0.020
Why?
Infant, Low Birth Weight
1
2008
153
0.020
Why?
Infant, Newborn
2
2010
6429
0.020
Why?
Gene Rearrangement
1
2008
155
0.020
Why?
Drug Therapy
1
2007
80
0.020
Why?
Lymph Nodes
1
2010
502
0.020
Why?
Prodrugs
1
2007
52
0.020
Why?
Adrenal Cortex Hormones
1
2010
478
0.020
Why?
Xenograft Model Antitumor Assays
1
2010
928
0.020
Why?
Tandem Mass Spectrometry
1
2010
576
0.020
Why?
RNA-Binding Proteins
1
2011
462
0.020
Why?
Pain Measurement
1
2009
552
0.020
Why?
Carboplatin
1
2007
160
0.020
Why?
Birth Weight
1
2010
522
0.020
Why?
Cerebral Hemorrhage
1
2007
120
0.020
Why?
Trabeculectomy
1
1987
75
0.020
Why?
Cell Growth Processes
1
2006
50
0.020
Why?
Prostheses and Implants
1
2008
141
0.020
Why?
Neoplasm Metastasis
1
1989
688
0.020
Why?
Legislation as Topic
1
1986
5
0.020
Why?
Gestational Age
1
2010
975
0.020
Why?
Injections
1
2007
196
0.020
Why?
Immunocompetence
1
2006
47
0.020
Why?
Enteral Nutrition
1
2008
216
0.010
Why?
Epidemiologic Methods
1
2006
89
0.010
Why?
Choroid Neoplasms
1
1986
9
0.010
Why?
Mice
3
2010
18339
0.010
Why?
Comorbidity
1
2011
1658
0.010
Why?
Phenotype
1
2014
3162
0.010
Why?
Stress, Mechanical
1
1988
494
0.010
Why?
Rabbits
1
2007
648
0.010
Why?
Attention Deficit Disorder with Hyperactivity
1
2010
428
0.010
Why?
Gene Silencing
1
2006
205
0.010
Why?
Tritium
1
2005
68
0.010
Why?
Imaging, Three-Dimensional
1
2009
583
0.010
Why?
Myelin Basic Protein
1
2005
44
0.010
Why?
Thymidine
1
2005
60
0.010
Why?
Nestin
1
2005
19
0.010
Why?
Bromodeoxyuridine
1
2005
79
0.010
Why?
Intermediate Filament Proteins
1
2005
57
0.010
Why?
Accidents, Traffic
1
1986
190
0.010
Why?
Pregnancy
2
2010
7190
0.010
Why?
Glial Fibrillary Acidic Protein
1
2005
124
0.010
Why?
RNA Interference
1
2006
476
0.010
Why?
Transcriptional Activation
1
2006
383
0.010
Why?
Embryo, Mammalian
1
2005
232
0.010
Why?
Genome-Wide Association Study
1
2011
1406
0.010
Why?
Microtubule-Associated Proteins
1
2005
196
0.010
Why?
Software
1
2009
690
0.010
Why?
Cannabis
1
2011
509
0.010
Why?
Adenoviridae Infections
3
1958
20
0.010
Why?
Infant, Premature
1
2008
611
0.010
Why?
Biocompatible Materials
1
2008
435
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
983
0.010
Why?
Length of Stay
1
2008
1337
0.010
Why?
Mice, Transgenic
1
2007
2182
0.010
Why?
Bed Rest
1
1981
15
0.010
Why?
Pediatrics
1
2010
1114
0.010
Why?
Antimetabolites, Antineoplastic
1
2002
105
0.010
Why?
Recovery of Function
1
2006
707
0.010
Why?
Immobilization
1
1981
53
0.010
Why?
Bupivacaine
1
1981
38
0.010
Why?
Joints
1
1982
107
0.010
Why?
Colectomy
1
2002
107
0.010
Why?
Nerve Tissue Proteins
1
2005
592
0.010
Why?
Disease Models, Animal
1
2011
4557
0.010
Why?
Hypertension
1
2009
1263
0.010
Why?
Oculomotor Muscles
1
1981
84
0.010
Why?
Suture Techniques
1
1981
131
0.010
Why?
Adenoviridae
2
1958
199
0.010
Why?
Movement
1
1982
293
0.010
Why?
Light Coagulation
1
1980
10
0.010
Why?
Gene Expression
1
2005
1490
0.010
Why?
HeLa Cells
2
1958
650
0.010
Why?
Rats, Sprague-Dawley
1
2005
2527
0.010
Why?
Preoperative Care
1
1981
379
0.010
Why?
Emergency Service, Hospital
1
2009
2310
0.010
Why?
Diabetic Retinopathy
1
1980
208
0.010
Why?
RNA, Messenger
1
2005
2832
0.010
Why?
Cryotherapy
1
1996
21
0.010
Why?
Laser Coagulation
1
1996
77
0.010
Why?
Mice, Inbred C57BL
1
2005
5992
0.010
Why?
Diabetes Mellitus
1
1982
1098
0.010
Why?
Polyarteritis Nodosa
1
1988
11
0.000
Why?
Virus Diseases
2
1956
216
0.000
Why?
Kidney Failure, Chronic
1
1988
598
0.000
Why?
Hand
1
1982
161
0.000
Why?
Adenovirus Vaccines
1
1958
2
0.000
Why?
Models, Biological
1
1986
1821
0.000
Why?
Neutralization Tests
1
1956
76
0.000
Why?
Antibody Formation
1
1956
294
0.000
Why?
Viruses
1
1956
165
0.000
Why?
Cell Culture Techniques
1
1956
375
0.000
Why?
Johnston's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)